Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 10/01/22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 01/11/21 |
Alan Scrivner
LAW | General Counsel | - | 01/09/21 |
Shannon McCarthy
HRO | Human Resources Officer | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 12/07/19 |
Eric Richman
BRD | Director/Board Member | 63 | 12/07/19 |
Gerald McDougall
BRD | Director/Board Member | 57 | 11/05/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 3 751 590 | 3 249 699 ( 86,62 %) | 0 | 86,62 % |
Coordinate società
NeuBase Therapeutics, Inc.
350 Technology Drive Suite 421
15219, Pittsburgh
+
http://www.neubasetherapeutics.com![Indirizzo OHR Pharmaceutical Inc](https://cdn.zonebourse.com/static/address/54095362.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+34,14% | 51,12 Mrd | |
-6,54% | 39,4 Mrd | |
+34,92% | 38,48 Mrd | |
+12,62% | 26,36 Mrd | |
-12,11% | 26,22 Mrd | |
-13,43% | 20,96 Mrd | |
+43,73% | 14,02 Mrd | |
+31,81% | 12,49 Mrd | |
-4,54% | 11,61 Mrd |